Tolerogenic Nanoparticles to Treat Islet Autoimmunity

Tolerogenic Nanoparticles to Treat Islet Autoimmunity Curr Diab Rep (2017) 17:84 DOI 10.1007/s11892-017-0914-z PATHOGENESIS OF TYPE 1 DIABETES (A PUGLIESE, SECTION EDITOR) 1 1 Tobias Neef & Stephen D. Miller Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review The current standard therapy for type 1 diabetes (T1D) is insulin replacement. Autoimmune diseases Type 1 diabetes (T1D) is an autoimmune disease in which are typically treated with broad immunosuppression, but this cells of the immune system destroy the insulin-producing β has multiple disadvantages. Induction of antigen-specific tol- cells located in the pancreatic islets of Langerhans. Disease erance is preferable. The application of nanomedicine to the onset can occur at any time, but most often happens at 5– problem of T1D can take different forms, but one promising 7 years of age or puberty, and there are about 280 million cases way is the development of tolerogenic nanoparticles, the aim worldwide today [1, 2]. Currently, the most common therapy of which is to mitigate the islet-destroying autoimmunity. We for T1D is insulin replacement [1–3]. Unfortunately, insulin review the topic and highlight recent strategies to produce replacement is not without its drawbacks. The discomfort of tolerogenic nanoparticles for the purpose of treating T1D. subcutaneous injection and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Diabetes Reports Springer Journals

Tolerogenic Nanoparticles to Treat Islet Autoimmunity

Loading next page...
 
/lp/springer_journal/tolerogenic-nanoparticles-to-treat-islet-autoimmunity-biIoX0Izuq
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Diabetes
ISSN
1534-4827
eISSN
1539-0829
D.O.I.
10.1007/s11892-017-0914-z
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial